Aspire Biopharma Holdings Statistics
Total Valuation
ASBP has a market cap or net worth of $1.03 million. The enterprise value is $5.40 million.
Important Dates
The last earnings date was Wednesday, April 8, 2026, after market close.
| Earnings Date | Apr 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASBP has 5.02 million shares outstanding. The number of shares has increased by 116.69% in one year.
| Current Share Class | 5.02M |
| Shares Outstanding | 5.02M |
| Shares Change (YoY) | +116.69% |
| Shares Change (QoQ) | +106.39% |
| Owned by Insiders (%) | 6.44% |
| Owned by Institutions (%) | 3.22% |
| Float | 4.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 198.47 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 871.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.17
| Current Ratio | 0.17 |
| Quick Ratio | 0.13 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.61 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -446.87% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 83.11% |
| Weighted Average Cost of Capital (WACC) | 107.08% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.96% in the last 52 weeks. The beta is 1.00, so ASBP's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | -98.96% |
| 50-Day Moving Average | 0.97 |
| 200-Day Moving Average | 8.12 |
| Relative Strength Index (RSI) | 29.81 |
| Average Volume (20 Days) | 26,338,889 |
Short Selling Information
The latest short interest is 373,385, so 7.43% of the outstanding shares have been sold short.
| Short Interest | 373,385 |
| Short Previous Month | 430,841 |
| Short % of Shares Out | 7.43% |
| Short % of Float | 8.56% |
| Short Ratio (days to cover) | 0.49 |
Income Statement
In the last 12 months, ASBP had revenue of $6,202 and -$24.48 million in losses. Loss per share was -$16.38.
| Revenue | 6,202 |
| Gross Profit | -116 |
| Operating Income | -5.22M |
| Pretax Income | -24.48M |
| Net Income | -24.48M |
| EBITDA | n/a |
| EBIT | -5.22M |
| Loss Per Share | -$16.38 |
Full Income StatementBalance Sheet
The company has $1.00 million in cash and $5.18 million in debt, giving a net cash position of -$4.17 million or -$0.83 per share.
| Cash & Cash Equivalents | 1.00M |
| Total Debt | 5.18M |
| Net Cash | -4.17M |
| Net Cash Per Share | -$0.83 |
| Equity (Book Value) | -6.38M |
| Book Value Per Share | -1.80 |
| Working Capital | -6.28M |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.92M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 6.57M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | -1.87% |
| Operating Margin | -84,167.06% |
| Pretax Margin | -394,725.06% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |